-+ 0.00%
-+ 0.00%
-+ 0.00%

Peptron Corrects PT403 Phase 1 Trial Approval Registration Number to 103673

PUBT·11/19/2026 07:18:58
Listen to the news
Peptron Corrects PT403 Phase 1 Trial Approval Registration Number to 103673
  • Peptron corrected the approval registration number for its PT403 Phase 1 trial to No. 103673 on Nov. 19, 2026.
  • The correction replaces electronic-system approval number 202600912 with the clinical trial approval certificate number.
  • South Korea's Ministry of Food and Drug Safety cleared the obesity drug trial on Nov. 18, 2026.
  • The study targets 22 healthy adults to assess safety, tolerability and pharmacokinetics, with completion expected Nov. 30, 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Peptron Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261119900374), on November 19, 2026, and is solely responsible for the information contained therein.